Vespula pensylvanica isolate Volc-1 chromosome 16, ASM1446617v1, whole genome shotgun sequence.
Vespula pensylvanica (western yellowjacket)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespula.
High-Quality Assemblies for Three Invasive Social Wasps from the Vespula Genus
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM025351.1.\nAssembly name: ASM1446617v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the University of Otago on\n2020/09/09. The original whole-genome shotgun project has the\naccession JACSDY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: University of Otago\nAssembly Date :: 03-JUL-2020\nAssembly Method :: meraculous v. 2.2.6\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 644x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespula pensylvanica Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC122634851, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC122634851, transcript variant X2
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X1
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X2
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X1
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X10
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X7
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X2
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X9
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X8
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X4
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X4
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X3
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X3
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X5
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X6
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X5
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X6
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like, transcript variant X11
dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like isoform X7
probable G-protein coupled receptor CG31760, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
probable G-protein coupled receptor CG31760, transcript variant X2
probable G-protein coupled receptor CG31760, transcript variant X1
probable G-protein coupled receptor CG31760, transcript variant X3
probable G-protein coupled receptor CG31760, transcript variant X4
probable G-protein coupled receptor CG31760, transcript variant X5
probable G-protein coupled receptor CG31760 isoform X1
probable G-protein coupled receptor CG31760 isoform X2
probable G-protein coupled receptor CG31760 isoform X3
probable G-protein coupled receptor CG31760 isoform X4
probable G-protein coupled receptor CG31760 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73% coverage of the annotated genomic feature by RNAseq alignments
tyrosine 3-monooxygenase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
tyrosine 3-monooxygenase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
tyrosine 3-monooxygenase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ras-related and estrogen-regulated growth inhibitor, transcript variant X10
ras-related and estrogen-regulated growth inhibitor, transcript variant X2
ras-related and estrogen-regulated growth inhibitor, transcript variant X7
ras-related and estrogen-regulated growth inhibitor, transcript variant X6
ras-related and estrogen-regulated growth inhibitor, transcript variant X1
ras-related and estrogen-regulated growth inhibitor, transcript variant X5
ras-related and estrogen-regulated growth inhibitor, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ras-related and estrogen-regulated growth inhibitor isoform X1
ras-related and estrogen-regulated growth inhibitor isoform X3
ras-related and estrogen-regulated growth inhibitor isoform X6
ras-related and estrogen-regulated growth inhibitor, transcript variant X8
ras-related and estrogen-regulated growth inhibitor, transcript variant X3
ras-related and estrogen-regulated growth inhibitor, transcript variant X4
ras-related and estrogen-regulated growth inhibitor isoform X2
ras-related and estrogen-regulated growth inhibitor isoform X5
ras-related and estrogen-regulated growth inhibitor isoform X4
transcription initiation factor IIE subunit beta
glutamate receptor 1, transcript variant X3
glutamate receptor 1, transcript variant X1
glutamate receptor 1, transcript variant X2
glutamate receptor 1, transcript variant X4
facilitated trehalose transporter Tret1-like
gamma-aminobutyric acid receptor subunit beta, transcript variant X8
gamma-aminobutyric acid receptor subunit beta, transcript variant X1
gamma-aminobutyric acid receptor subunit beta, transcript variant X2
gamma-aminobutyric acid receptor subunit beta, transcript variant X4
gamma-aminobutyric acid receptor subunit beta, transcript variant X3
gamma-aminobutyric acid receptor subunit beta, transcript variant X6
gamma-aminobutyric acid receptor subunit beta, transcript variant X7
gamma-aminobutyric acid receptor subunit beta, transcript variant X11
gamma-aminobutyric acid receptor subunit beta, transcript variant X18
gamma-aminobutyric acid receptor subunit beta, transcript variant X9
gamma-aminobutyric acid receptor subunit beta, transcript variant X13
gamma-aminobutyric acid receptor subunit beta, transcript variant X16
gamma-aminobutyric acid receptor subunit beta, transcript variant X5
gamma-aminobutyric acid receptor subunit beta, transcript variant X12
gamma-aminobutyric acid receptor subunit beta, transcript variant X15
gamma-aminobutyric acid receptor subunit beta, transcript variant X10
gamma-aminobutyric acid receptor subunit beta, transcript variant X14
gamma-aminobutyric acid receptor subunit beta, transcript variant X17
gamma-aminobutyric acid receptor subunit beta isoform X1
gamma-aminobutyric acid receptor subunit beta isoform X3
gamma-aminobutyric acid receptor subunit beta isoform X4
gamma-aminobutyric acid receptor subunit beta isoform X8
gamma-aminobutyric acid receptor subunit beta isoform X15
gamma-aminobutyric acid receptor subunit beta isoform X6
gamma-aminobutyric acid receptor subunit beta isoform X10
gamma-aminobutyric acid receptor subunit beta isoform X13
gamma-aminobutyric acid receptor subunit beta isoform X2
gamma-aminobutyric acid receptor subunit beta isoform X9
gamma-aminobutyric acid receptor subunit beta isoform X12
gamma-aminobutyric acid receptor subunit beta isoform X7
gamma-aminobutyric acid receptor subunit beta isoform X11
gamma-aminobutyric acid receptor subunit beta isoform X14
gamma-aminobutyric acid receptor subunit beta isoform X5
gamma-aminobutyric acid receptor subunit beta, transcript variant X20
gamma-aminobutyric acid receptor subunit beta, transcript variant X19
gamma-aminobutyric acid receptor subunit beta isoform X16
zinc finger and BTB domain-containing protein 14-like, transcript variant X8
zinc finger and BTB domain-containing protein 14-like, transcript variant X10
zinc finger and BTB domain-containing protein 14-like, transcript variant X7
zinc finger and BTB domain-containing protein 14-like, transcript variant X4
zinc finger and BTB domain-containing protein 14-like, transcript variant X9
zinc finger and BTB domain-containing protein 14-like, transcript variant X6
zinc finger and BTB domain-containing protein 14-like, transcript variant X5
zinc finger and BTB domain-containing protein 14-like, transcript variant X3
zinc finger and BTB domain-containing protein 14-like, transcript variant X2
zinc finger and BTB domain-containing protein 14-like, transcript variant X1
zinc finger and BTB domain-containing protein 14-like isoform X1
zinc finger and BTB domain-containing protein 14-like isoform X2
zinc finger and BTB domain-containing protein 14-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 14-like isoform X3
protein downstream neighbor of son homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
serine/threonine-protein kinase mig-15, transcript variant X8
serine/threonine-protein kinase mig-15, transcript variant X3
serine/threonine-protein kinase mig-15, transcript variant X7
serine/threonine-protein kinase mig-15, transcript variant X5
serine/threonine-protein kinase mig-15, transcript variant X4
serine/threonine-protein kinase mig-15, transcript variant X2
serine/threonine-protein kinase mig-15, transcript variant X1
serine/threonine-protein kinase mig-15, transcript variant X15
serine/threonine-protein kinase mig-15, transcript variant X14
serine/threonine-protein kinase mig-15, transcript variant X10
serine/threonine-protein kinase mig-15, transcript variant X9
serine/threonine-protein kinase mig-15, transcript variant X6
serine/threonine-protein kinase mig-15, transcript variant X12
serine/threonine-protein kinase mig-15, transcript variant X11
serine/threonine-protein kinase mig-15, transcript variant X17
serine/threonine-protein kinase mig-15, transcript variant X16
serine/threonine-protein kinase mig-15, transcript variant X13
serine/threonine-protein kinase mig-15 isoform X15
serine/threonine-protein kinase mig-15 isoform X14
serine/threonine-protein kinase mig-15 isoform X8
serine/threonine-protein kinase mig-15 isoform X3
serine/threonine-protein kinase mig-15 isoform X7
serine/threonine-protein kinase mig-15 isoform X5
serine/threonine-protein kinase mig-15 isoform X4
serine/threonine-protein kinase mig-15 isoform X17
serine/threonine-protein kinase mig-15 isoform X12
serine/threonine-protein kinase mig-15 isoform X10
serine/threonine-protein kinase mig-15 isoform X2
serine/threonine-protein kinase mig-15 isoform X16
serine/threonine-protein kinase mig-15 isoform X11
serine/threonine-protein kinase mig-15 isoform X9
serine/threonine-protein kinase mig-15 isoform X6
serine/threonine-protein kinase mig-15 isoform X1
serine/threonine-protein kinase mig-15 isoform X13
PHD finger protein 20, transcript variant X5
PHD finger protein 20, transcript variant X4
PHD finger protein 20, transcript variant X3
PHD finger protein 20, transcript variant X2
PHD finger protein 20, transcript variant X6
PHD finger protein 20, transcript variant X1
PHD finger protein 20, transcript variant X7
NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial
protein SYS1 homolog, transcript variant X3
protein SYS1 homolog, transcript variant X4
protein SYS1 homolog, transcript variant X1
protein SYS1 homolog, transcript variant X2
hormone-sensitive lipase, transcript variant X2
hormone-sensitive lipase, transcript variant X3
hormone-sensitive lipase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
hormone-sensitive lipase, transcript variant X4
hormone-sensitive lipase, transcript variant X1
hormone-sensitive lipase, transcript variant X7
hormone-sensitive lipase, transcript variant X5
hormone-sensitive lipase, transcript variant X8
probable N-acetyltransferase san, transcript variant X2
probable N-acetyltransferase san, transcript variant X1
probable N-acetyltransferase san isoform X2
uncharacterized LOC122634799, transcript variant X2
uncharacterized LOC122634799, transcript variant X1
uncharacterized LOC122634799, transcript variant X4
uncharacterized LOC122634799, transcript variant X3
uncharacterized protein LOC122634799 isoform X1
uncharacterized protein LOC122634799 isoform X2
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase-like
tryptophan--tRNA ligase, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tryptophan--tRNA ligase, mitochondrial, transcript variant X1
tryptophan--tRNA ligase, mitochondrial isoform X1
tryptophan--tRNA ligase, mitochondrial isoform X2
reticulon-4-interacting protein 1, mitochondrial
protein still life, isoforms C/SIF type 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein still life, isoforms C/SIF type 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
protein still life, isoforms C/SIF type 2, transcript variant X4
protein still life, isoforms C/SIF type 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
protein still life, isoforms C/SIF type 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
protein still life, isoforms C/SIF type 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
protein still life, isoform SIF type 1 isoform X2
protein still life, isoform SIF type 1 isoform X1
protein still life, isoform SIF type 1 isoform X6
protein still life, isoform SIF type 1 isoform X4
protein still life, isoform SIF type 1 isoform X5
protein still life, isoform SIF type 1 isoform X3
protein still life, isoforms C/SIF type 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
protein still life, isoforms C/SIF type 2, transcript variant X8
protein still life, isoforms C/SIF type 2 isoform X7
protein still life, isoforms C/SIF type 2 isoform X8
protein still life, isoforms C/SIF type 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protein still life, isoforms C/SIF type 2 isoform X9
NPC intracellular cholesterol transporter 1 homolog 1b-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NPC intracellular cholesterol transporter 1 homolog 1b-like, transcript variant X4
NPC intracellular cholesterol transporter 1 homolog 1b-like, transcript variant X1
NPC intracellular cholesterol transporter 1 homolog 1b-like, transcript variant X2
NPC intracellular cholesterol transporter 1 homolog 1b-like isoform X1
NPC intracellular cholesterol transporter 1 homolog 1b-like isoform X2
NPC intracellular cholesterol transporter 1 homolog 1b-like isoform X3
pre-mRNA-splicing factor syf1 homolog, transcript variant X1
pre-mRNA-splicing factor syf1 homolog, transcript variant X2
pre-mRNA-splicing factor syf1 homolog isoform X1
pre-mRNA-splicing factor syf1 homolog isoform X2
F-box only protein 42, transcript variant X3
F-box only protein 42, transcript variant X1
F-box only protein 42, transcript variant X2
peroxisomal membrane protein PEX14, transcript variant X2
peroxisomal membrane protein PEX14, transcript variant X1
CTD nuclear envelope phosphatase 1 homolog, transcript variant X2
CTD nuclear envelope phosphatase 1 homolog isoform X2
CTD nuclear envelope phosphatase 1 homolog, transcript variant X1
CTD nuclear envelope phosphatase 1 homolog, transcript variant X3
CTD nuclear envelope phosphatase 1 homolog isoform X3
CTD nuclear envelope phosphatase 1 homolog isoform X1
mRNA-decapping enzyme 1A, transcript variant X1
mRNA-decapping enzyme 1A, transcript variant X4
mRNA-decapping enzyme 1A, transcript variant X2
mRNA-decapping enzyme 1A, transcript variant X3
BMP and activin membrane-bound inhibitor homolog
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X7
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X8
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X4
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X6
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X5
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X1
uncharacterized protein LOC122634805 isoform X1
uncharacterized protein LOC122634805 isoform X4
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC122634805 isoform X3
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC122634805 isoform X2
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 isoform X5
uncharacterized LOC122634813, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized protein LOC122634813 isoform X2
uncharacterized LOC122634813, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC122634813 isoform X1
splicing factor 3B subunit 4, transcript variant X2
splicing factor 3B subunit 4, transcript variant X1
ribonucleoside-diphosphate reductase large subunit-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X1
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X2
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X3
biogenesis of lysosome-related organelles complex 1 subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 131 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
odorant receptor 46a-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
odorant receptor 46a-like, transcript variant X1
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X2
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, transcript variant X1
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 isoform X2
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 isoform X1
F-box/LRR-repeat protein 20, transcript variant X2
F-box/LRR-repeat protein 20, transcript variant X1
F-box/LRR-repeat protein 20, transcript variant X3
F-box/LRR-repeat protein 20, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC122634992
uncharacterized LOC122634917, transcript variant X2
uncharacterized LOC122634917, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
serine protease filzig, transcript variant X2
serine protease filzig, transcript variant X4
serine protease filzig, transcript variant X3
serine protease filzig, transcript variant X1
unconventional myosin-Va, transcript variant X2
unconventional myosin-Va, transcript variant X4
unconventional myosin-Va, transcript variant X1
unconventional myosin-Va, transcript variant X5
unconventional myosin-Va, transcript variant X3
uncharacterized LOC122634949, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC122634949 isoform X2
uncharacterized LOC122634949, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122634949, transcript variant X2
uncharacterized protein LOC122634949 isoform X1
uncharacterized LOC122634950, transcript variant X1
uncharacterized LOC122634950, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122634950, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC122634950, transcript variant X6
uncharacterized protein LOC122634950 isoform X1
uncharacterized protein LOC122634950 isoform X2
uncharacterized protein LOC122634950 isoform X3
uncharacterized protein LOC122634950 isoform X5
uncharacterized LOC122634950, transcript variant X4
uncharacterized LOC122634950, transcript variant X5
uncharacterized protein LOC122634950 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins
succinate dehydrogenase assembly factor 3, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
nucleoside diphosphate-linked moiety X motif 19, transcript variant X1
nucleoside diphosphate-linked moiety X motif 19, transcript variant X2
nucleoside diphosphate-linked moiety X motif 19
60S ribosomal protein L28, transcript variant X1
60S ribosomal protein L28, transcript variant X2
ejaculatory bulb-specific protein 3, transcript variant X2
ejaculatory bulb-specific protein 3 isoform X2
ejaculatory bulb-specific protein 3, transcript variant X1
ejaculatory bulb-specific protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeat-containing protein 24-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
leucine-rich repeat-containing protein 24-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
leucine-rich repeat-containing protein 24-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
leucine-rich repeat-containing protein 24-like, transcript variant X5
leucine-rich repeat-containing protein 24-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat-containing protein 24-like, transcript variant X4
leucine-rich repeat-containing protein 24-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
leucine-rich repeat-containing protein 24-like, transcript variant X8
leucine-rich repeat-containing protein 24-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker isoform X1
potassium voltage-gated channel protein Shaker isoform X2
potassium voltage-gated channel protein Shaker isoform X4
potassium voltage-gated channel protein Shaker isoform X3
potassium voltage-gated channel protein Shaker isoform X6
potassium voltage-gated channel protein Shaker isoform X5
potassium voltage-gated channel protein Shaker isoform X7
potassium voltage-gated channel protein Shaker, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
putative uncharacterized protein DDB_G0283431
uncharacterized LOC122634849, transcript variant X1
uncharacterized LOC122634849, transcript variant X3
uncharacterized LOC122634849, transcript variant X2
U1 small nuclear ribonucleoprotein 70 kDa-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: U1 small nuclear ribonucleoprotein 70 kDa-like
protein O-mannosyl-transferase Tmtc3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
ras-related protein Ral-a, transcript variant X7
ras-related protein Ral-a, transcript variant X5
ras-related protein Ral-a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
ras-related protein Ral-a, transcript variant X2
ras-related protein Ral-a, transcript variant X1
ras-related protein Ral-a, transcript variant X4
ras-related protein Ral-a, transcript variant X3
stromal interaction molecule homolog, transcript variant X1
stromal interaction molecule homolog, transcript variant X2
stromal interaction molecule homolog isoform X1
stromal interaction molecule homolog, transcript variant X3
stromal interaction molecule homolog isoform X2
serine palmitoyltransferase 2, transcript variant X2
serine palmitoyltransferase 2, transcript variant X1
32 kDa beta-galactoside-binding lectin lec-3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
32 kDa beta-galactoside-binding lectin lec-3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
32 kDa beta-galactoside-binding lectin lec-3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
32 kDa beta-galactoside-binding lectin lec-3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X20
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X18
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X12
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X9
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X13
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X5
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X19
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X6
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X14
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X7
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X11
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X21
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X31
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X8
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X30
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X29
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X15
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X28
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X27
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X26
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X25
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X10
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X1
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X17
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X23
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X4
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X3
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X22
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X16
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X2
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X19
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X17
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X12
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X9
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X13
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X5
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X18
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X6
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X14
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X7
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X11
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X20
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X30
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X8
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X29
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X28
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X15
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X27
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X26
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X25
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X24
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X10
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X1
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X22
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X4
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X3
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X21
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X2
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase isoform X16
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 isoform X23
mitochondrial thiamine pyrophosphate carrier-like, transcript variant X1
mitochondrial thiamine pyrophosphate carrier-like, transcript variant X2
mitochondrial thiamine pyrophosphate carrier-like
ATP-dependent RNA helicase p62-like, transcript variant X2
ATP-dependent RNA helicase p62-like, transcript variant X4
ATP-dependent RNA helicase p62-like, transcript variant X5
ATP-dependent RNA helicase p62-like, transcript variant X7
ATP-dependent RNA helicase p62-like, transcript variant X8
ATP-dependent RNA helicase p62-like, transcript variant X10
ATP-dependent RNA helicase p62-like, transcript variant X3
ATP-dependent RNA helicase p62-like, transcript variant X6
ATP-dependent RNA helicase p62-like, transcript variant X9
ATP-dependent RNA helicase p62-like, transcript variant X1
ATP-dependent RNA helicase p62-like isoform X1
ATP-dependent RNA helicase p62-like isoform X2
ATP-dependent RNA helicase p62-like isoform X3
ATP-dependent RNA helicase p62-like isoform X4
histidine protein methyltransferase 1 homolog
pyridoxine/pyridoxamine 5'-phosphate oxidase-like
signal recognition particle receptor subunit beta
uncharacterized LOC122634792, transcript variant X3
uncharacterized LOC122634792, transcript variant X1
uncharacterized LOC122634792, transcript variant X2
uncharacterized LOC122634792, transcript variant X4
uncharacterized protein LOC122634792 isoform X1
uncharacterized protein LOC122634792 isoform X2
EF-hand calcium-binding domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 61% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 6, transcription factor 1, transcript variant X5
POU domain, class 6, transcription factor 1, transcript variant X3
POU domain, class 6, transcription factor 1, transcript variant X1
POU domain, class 6, transcription factor 1, transcript variant X4
POU domain, class 6, transcription factor 1, transcript variant X2
POU domain, class 6, transcription factor 2 isoform X1
POU domain, class 6, transcription factor 2 isoform X2
POU domain, class 6, transcription factor 1 isoform X3
POU domain, class 6, transcription factor 1 isoform X4
POU domain, class 6, transcription factor 2 isoform X5
POU domain, class 6, transcription factor 1, transcript variant X6
POU domain, class 6, transcription factor 2 isoform X6
metabotropic glutamate receptor 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC122634865 isoform X1
metabotropic glutamate receptor 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
metabotropic glutamate receptor 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
metabotropic glutamate receptor 2-like, transcript variant X2
metabotropic glutamate receptor 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
metabotropic glutamate receptor 2-like, transcript variant X6
metabotropic glutamate receptor 2-like isoform X2
COP9 signalosome complex subunit 7, transcript variant X2
COP9 signalosome complex subunit 7 isoform X2
COP9 signalosome complex subunit 7, transcript variant X1
COP9 signalosome complex subunit 7 isoform X1
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2, transcript variant X2
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 isoform X1
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 isoform X2
transcriptional activator cubitus interruptus, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transcriptional activator cubitus interruptus, transcript variant X1
transcriptional activator cubitus interruptus, transcript variant X2
transcriptional activator cubitus interruptus, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transcriptional activator cubitus interruptus, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transcriptional activator cubitus interruptus isoform X3
uncharacterized LOC122634869, transcript variant X3
uncharacterized LOC122634869, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC122634869, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC122634869, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized protein LOC122634869 isoform X1
uncharacterized LOC122634869, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
uncharacterized protein LOC122634869 isoform X2
uncharacterized protein LOC122634869 isoform X3
eukaryotic initiation factor 4A-I, transcript variant X1
eukaryotic initiation factor 4A-I, transcript variant X2
uncharacterized LOC122634864, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122634864, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
amyloid protein-binding protein 2, transcript variant X2
amyloid protein-binding protein 2, transcript variant X1
amyloid protein-binding protein 2 isoform X1
amyloid protein-binding protein 2 isoform X2
receptor-mediated endocytosis protein 6 homolog, transcript variant X1
receptor-mediated endocytosis protein 6 homolog, transcript variant X4
receptor-mediated endocytosis protein 6 homolog, transcript variant X5
receptor-mediated endocytosis protein 6 homolog, transcript variant X7
receptor-mediated endocytosis protein 6 homolog, transcript variant X2
receptor-mediated endocytosis protein 6 homolog, transcript variant X3
receptor-mediated endocytosis protein 6 homolog isoform X1
receptor-mediated endocytosis protein 6 homolog isoform X2
receptor-mediated endocytosis protein 6 homolog isoform X3
GTPase-activating protein and VPS9 domain-containing protein 1 isoform X5
receptor-mediated endocytosis protein 6 homolog, transcript variant X6
receptor-mediated endocytosis protein 6 homolog isoform X4
sodium/potassium-transporting ATPase subunit beta-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
intraflagellar transport protein 80 homolog
sodium/potassium-transporting ATPase subunit beta-2
glycerophosphocholine phosphodiesterase GPCPD1-like, transcript variant X1
glycerophosphocholine phosphodiesterase GPCPD1-like, transcript variant X2
glycerophosphocholine phosphodiesterase GPCPD1-like isoform X2
glycerophosphocholine phosphodiesterase GPCPD1-like isoform X1
general transcription factor II-I repeat domain-containing protein 2-like
glutamate synthase [NADH], transcript variant X2
glutamate synthase [NADH], transcript variant X1
glutamate synthase [NADH], transcript variant X4
glutamate synthase [NADH], transcript variant X3
glutamate synthase [NADH], transcript variant X6
glutamate synthase [NADH], transcript variant X5
uncharacterized LOC122634920, transcript variant X1
uncharacterized LOC122634920, transcript variant X2
uncharacterized LOC122634920, transcript variant X3
uncharacterized protein LOC122634920 isoform X2
uncharacterized protein LOC122634920 isoform X3
uncharacterized protein LOC122634920 isoform X1
uncharacterized LOC122634936, transcript variant X3
uncharacterized LOC122634936, transcript variant X1
uncharacterized LOC122634936, transcript variant X2
uncharacterized LOC122634936, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122634934, transcript variant X3
uncharacterized LOC122634934, transcript variant X1
uncharacterized LOC122634934, transcript variant X2
uncharacterized LOC122634940, transcript variant X1
uncharacterized LOC122634940, transcript variant X3
uncharacterized LOC122634940, transcript variant X2
cytoskeletal protein Sojo, transcript variant X3
cytoskeletal protein Sojo, transcript variant X1
cytoskeletal protein Sojo, transcript variant X4
cytoskeletal protein Sojo, transcript variant X2
cytoskeletal protein Sojo, transcript variant X5
kynurenine 3-monooxygenase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kynurenine 3-monooxygenase, transcript variant X1
kynurenine 3-monooxygenase, transcript variant X3
GTPase-activating protein skywalker, transcript variant X1
GTPase-activating protein skywalker, transcript variant X3
GTPase-activating protein skywalker, transcript variant X2
GTPase-activating protein skywalker, transcript variant X4
GTPase-activating protein skywalker, transcript variant X5
GTPase-activating protein skywalker, transcript variant X6
GTPase-activating protein skywalker isoform X1
GTPase-activating protein skywalker isoform X3
GTPase-activating protein skywalker isoform X2
GTPase-activating protein skywalker isoform X4
ATP-binding cassette sub-family G member 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dehydrogenase/reductase SDR family member 7, transcript variant X4
ATP-binding cassette sub-family G member 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ATP-binding cassette sub-family G member 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ATP-binding cassette sub-family G member 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ATP-binding cassette sub-family G member 1-like isoform X1
ATP-binding cassette sub-family G member 1-like isoform X2
dehydrogenase/reductase SDR family member 7, transcript variant X1
dehydrogenase/reductase SDR family member 7, transcript variant X2
dehydrogenase/reductase SDR family member 7, transcript variant X3
dehydrogenase/reductase SDR family member 7
ATP-binding cassette sub-family C member 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ATP-binding cassette sub-family C member 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ATP-binding cassette sub-family C member 4-like isoform X2
ATP-binding cassette sub-family C member 4-like isoform X1
ATP-binding cassette sub-family C member 4-like, transcript variant X3
ATP-binding cassette sub-family C member 4-like
serine/threonine-protein kinase polo, transcript variant X1
serine/threonine-protein kinase polo, transcript variant X2
serine/threonine-protein kinase polo isoform X2
serine/threonine-protein kinase polo isoform X1
glycine-rich protein DOT1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
glycine-rich protein DOT1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
glycine-rich protein DOT1-like, transcript variant X1
glycine-rich protein DOT1-like, transcript variant X5
glycine-rich protein DOT1-like, transcript variant X3
glycine-rich protein DOT1-like, transcript variant X2
glycine-rich protein DOT1-like isoform X2
glycine-rich protein DOT1-like isoform X4
glycine-rich protein DOT1-like isoform X1
glycine-rich protein DOT1-like isoform X3
uncharacterized protein DDB_G0271670-like, transcript variant X1
uncharacterized protein DDB_G0271670-like, transcript variant X2
uncharacterized protein DDB_G0271670-like, transcript variant X3
uncharacterized protein DDB_G0271670-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
armadillo repeat-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC122635015, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC122635015, transcript variant X2
poly(A) RNA polymerase gld-2 homolog A-like, transcript variant X4
poly(A) RNA polymerase gld-2 homolog A-like, transcript variant X3
poly(A) RNA polymerase gld-2 homolog A-like, transcript variant X1
poly(A) RNA polymerase gld-2 homolog A-like, transcript variant X2
poly(A) RNA polymerase gld-2 homolog A-like isoform X1
poly(A) RNA polymerase gld-2 homolog A-like isoform X2
poly(A) RNA polymerase gld-2 homolog A-like isoform X3
probable WRKY transcription factor protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
probable WRKY transcription factor protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
probable WRKY transcription factor protein 1 isoform X1
probable WRKY transcription factor protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
armadillo repeat protein deleted in velo-cardio-facial syndrome isoform X1
armadillo repeat protein deleted in velo-cardio-facial syndrome isoform X2
armadillo repeat protein deleted in velo-cardio-facial syndrome isoform X3
armadillo repeat protein deleted in velo-cardio-facial syndrome isoform X4
armadillo repeat protein deleted in velo-cardio-facial syndrome isoform X6
armadillo repeat protein deleted in velo-cardio-facial syndrome isoform X7
one cut domain family member 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
one cut domain family member 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
one cut domain family member 2-like, transcript variant X3
one cut domain family member 2-like, transcript variant X4
one cut domain family member 2-like, transcript variant X5
one cut domain family member 2-like isoform X1
one cut domain family member 2-like isoform X2
AT-rich interactive domain-containing protein 1B-like isoform X3
AT-rich interactive domain-containing protein 1B-like isoform X4
AT-rich interactive domain-containing protein 1B-like isoform X5
glutaryl-CoA dehydrogenase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 15-like, transcript variant X2
mediator of RNA polymerase II transcription subunit 15-like, transcript variant X1
mediator of RNA polymerase II transcription subunit 15-like isoform X1
mediator of RNA polymerase II transcription subunit 15-like isoform X2
ubiquitin carboxyl-terminal hydrolase calypso, transcript variant X3
ubiquitin carboxyl-terminal hydrolase calypso, transcript variant X1
ubiquitin carboxyl-terminal hydrolase calypso, transcript variant X2
ubiquitin carboxyl-terminal hydrolase calypso, transcript variant X4
ubiquitin carboxyl-terminal hydrolase calypso isoform X3
ubiquitin carboxyl-terminal hydrolase calypso isoform X1
ubiquitin carboxyl-terminal hydrolase calypso isoform X2
ubiquitin carboxyl-terminal hydrolase calypso isoform X4
transcription initiation factor TFIID subunit 6-like, transcript variant X1
transcription initiation factor TFIID subunit 6-like, transcript variant X2
transcription initiation factor TFIID subunit 6-like isoform X2
transcription initiation factor TFIID subunit 6-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
ER degradation-enhancing alpha-mannosidase-like protein 2
protein polybromo-1, transcript variant X3
protein polybromo-1, transcript variant X2
protein polybromo-1, transcript variant X5
protein polybromo-1, transcript variant X8
protein polybromo-1, transcript variant X9
protein polybromo-1, transcript variant X6
protein polybromo-1, transcript variant X1
protein polybromo-1, transcript variant X7
protein polybromo-1, transcript variant X4
protein polybromo-1, transcript variant X10
facilitated trehalose transporter Tret1-like, transcript variant X1
facilitated trehalose transporter Tret1-like, transcript variant X2
facilitated trehalose transporter Tret1-like isoform X1
facilitated trehalose transporter Tret1-like isoform X2
facilitated trehalose transporter Tret1-like, transcript variant X3
facilitated trehalose transporter Tret1-like isoform X3
hemicentin-1-like, transcript variant X4
hemicentin-1-like, transcript variant X1
hemicentin-1-like, transcript variant X2
hemicentin-1-like, transcript variant X3
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X2
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X5
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X4
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X1
ras-specific guanine nucleotide-releasing factor 2-like, transcript variant X3
ras-specific guanine nucleotide-releasing factor 2-like isoform X2
ras-specific guanine nucleotide-releasing factor 2-like isoform X4
ras-specific guanine nucleotide-releasing factor 2-like isoform X3
ras-specific guanine nucleotide-releasing factor 2-like isoform X1
guanine nucleotide-binding protein G(o) subunit alpha, transcript variant X4
guanine nucleotide-binding protein G(o) subunit alpha, transcript variant X1
guanine nucleotide-binding protein G(o) subunit alpha, transcript variant X2
guanine nucleotide-binding protein G(o) subunit alpha, transcript variant X3
guanine nucleotide-binding protein G(o) subunit alpha, transcript variant X5
guanine nucleotide-binding protein G(o) subunit alpha
DNA replication complex GINS protein PSF3
hepatocyte nuclear factor 4-gamma, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
hepatocyte nuclear factor 4-gamma, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
hepatocyte nuclear factor 4-gamma, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
hepatocyte nuclear factor 4-gamma, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
hepatocyte nuclear factor 4-gamma, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
hepatocyte nuclear factor 4-gamma, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
hepatocyte nuclear factor 4-gamma, transcript variant X7
hepatocyte nuclear factor 4-gamma isoform X2
hepatocyte nuclear factor 4-gamma isoform X1
hepatocyte nuclear factor 4-gamma isoform X3
hepatocyte nuclear factor 4-gamma isoform X4
hepatocyte nuclear factor 4-gamma isoform X5
E3 ubiquitin-protein ligase AMFR-like, transcript variant X1
E3 ubiquitin-protein ligase AMFR-like, transcript variant X2
E3 ubiquitin-protein ligase AMFR-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
E3 ubiquitin-protein ligase AMFR-like isoform X1
E3 ubiquitin-protein ligase AMFR-like isoform X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1
MAP/microtubule affinity-regulating kinase 3-like, transcript variant X1
SNF1-related protein kinase catalytic subunit alpha KIN12-like isoform X1
MAP/microtubule affinity-regulating kinase 3-like, transcript variant X2
MAP/microtubule affinity-regulating kinase 3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
lysosomal acid phosphatase-like, transcript variant X1
lysosomal acid phosphatase-like, transcript variant X2
prostatic acid phosphatase-like isoform X1
lysosomal acid phosphatase-like isoform X2
EH domain-containing protein 3, transcript variant X1
EH domain-containing protein 3, transcript variant X3
EH domain-containing protein 3, transcript variant X2
signal recognition particle 14 kDa protein
ubiquitin carboxyl-terminal hydrolase 34, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 34, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 34 isoform X2
ubiquitin carboxyl-terminal hydrolase 34 isoform X1
AT-rich interactive domain-containing protein 4A, transcript variant X3
AT-rich interactive domain-containing protein 4A, transcript variant X2
AT-rich interactive domain-containing protein 4A, transcript variant X1
AT-rich interactive domain-containing protein 4A isoform X3
AT-rich interactive domain-containing protein 4A isoform X2
AT-rich interactive domain-containing protein 4A isoform X1
protein arginine N-methyltransferase 1, transcript variant X1
protein arginine N-methyltransferase 1, transcript variant X3
protein arginine N-methyltransferase 1, transcript variant X4
protein arginine N-methyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
methylglutaconyl-CoA hydratase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
H(+)/Cl(-) exchange transporter 4, transcript variant X1
H(+)/Cl(-) exchange transporter 4, transcript variant X3
H(+)/Cl(-) exchange transporter 4, transcript variant X2
H(+)/Cl(-) exchange transporter 4 isoform X1
H(+)/Cl(-) exchange transporter 4 isoform X2
GPI ethanolamine phosphate transferase 1-like
eukaryotic translation initiation factor 3 subunit K
multiple epidermal growth factor-like domains protein 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
multiple epidermal growth factor-like domains protein 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
multiple epidermal growth factor-like domains protein 8 isoform X1
multiple epidermal growth factor-like domains protein 8 isoform X2
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X2
mitochondrial tRNA-specific 2-thiouridylase 1, transcript variant X1
mitochondrial tRNA-specific 2-thiouridylase 1
paired amphipathic helix protein Sin3a, transcript variant X1
paired amphipathic helix protein Sin3a, transcript variant X10
paired amphipathic helix protein Sin3a, transcript variant X6
paired amphipathic helix protein Sin3a, transcript variant X7
paired amphipathic helix protein Sin3a, transcript variant X9
paired amphipathic helix protein Sin3a, transcript variant X8
paired amphipathic helix protein Sin3a, transcript variant X5
paired amphipathic helix protein Sin3a, transcript variant X4
paired amphipathic helix protein Sin3a, transcript variant X3
paired amphipathic helix protein Sin3a, transcript variant X2
paired amphipathic helix protein Sin3a isoform X1
paired amphipathic helix protein Sin3a isoform X6
paired amphipathic helix protein Sin3a isoform X2
paired amphipathic helix protein Sin3a isoform X3
paired amphipathic helix protein Sin3a isoform X5
paired amphipathic helix protein Sin3a isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
cytochrome P450 4c3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cytochrome P450 4c3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X1
phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform X1
phosphatidylinositol N-acetylglucosaminyltransferase subunit A, transcript variant X2
phosphatidylinositol N-acetylglucosaminyltransferase subunit A isoform X2
GIGYF family protein Gyf-like, transcript variant X2
GIGYF family protein Gyf-like, transcript variant X1
GRB10-interacting GYF protein 2-like isoform X2
GIGYF family protein Gyf-like isoform X1
TM2 domain-containing protein CG10795, transcript variant X3
TM2 domain-containing protein CG10795, transcript variant X1
TM2 domain-containing protein CG10795, transcript variant X2
TM2 domain-containing protein CG10795 isoform X1
TM2 domain-containing protein CG10795 isoform X2
TM2 domain-containing protein CG10795 isoform X3
uncharacterized LOC122634980, transcript variant X1
uncharacterized LOC122634980, transcript variant X3
uncharacterized LOC122634980, transcript variant X2
uncharacterized protein LOC122634980 isoform X1
uncharacterized protein LOC122634980 isoform X2
uncharacterized protein LOC122634980 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CDK5 and ABL1 enzyme substrate 1, transcript variant X5
CDK5 and ABL1 enzyme substrate 1, transcript variant X4
CDK5 and ABL1 enzyme substrate 1, transcript variant X3
CDK5 and ABL1 enzyme substrate 1, transcript variant X2
CDK5 and ABL1 enzyme substrate 1, transcript variant X1
CDK5 and ABL1 enzyme substrate 1 isoform X4
CDK5 and ABL1 enzyme substrate 1 isoform X3
CDK5 and ABL1 enzyme substrate 1 isoform X2
CDK5 and ABL1 enzyme substrate 1 isoform X1
uncharacterized LOC122634977, transcript variant X2
uncharacterized LOC122634977, transcript variant X1
uncharacterized protein LOC122634977 isoform X2
uncharacterized protein LOC122634977 isoform X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
asparagine synthetase domain-containing protein 1, transcript variant X1
asparagine synthetase domain-containing protein 1, transcript variant X2
asparagine synthetase domain-containing protein 1, transcript variant X4
asparagine synthetase domain-containing protein 1, transcript variant X3
asparagine synthetase domain-containing protein CG17486 isoform X1
asparagine synthetase domain-containing protein 1 isoform X2
probable serine/threonine-protein kinase DDB_G0280133, transcript variant X2
probable serine/threonine-protein kinase DDB_G0280133, transcript variant X1
probable serine/threonine-protein kinase DDB_G0280133
replication factor C subunit 4, transcript variant X2
replication factor C subunit 4, transcript variant X1
replication factor C subunit 4, transcript variant X3
stress response protein NST1, transcript variant X1
stress response protein NST1, transcript variant X2
phospholipid scramblase 2-like, transcript variant X1
phospholipid scramblase 2-like, transcript variant X3
phospholipid scramblase 2-like, transcript variant X4
phospholipid scramblase 2-like, transcript variant X2